Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06423495Not ApplicableRecruiting

Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19

Role: lead

NCT05090553Not ApplicableUnknown

Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques

Role: lead

NCT04807699Unknown

Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL

Role: collaborator

NCT02648555Not ApplicableUnknown

A Lifestyle Intervention to Improve in Vitro Fertilization Results

Role: collaborator

All 4 trials loaded